BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34698976)

  • 1. Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway.
    Moshina N; Falk RS; Botteri E; Larsen M; Akslen LA; Cairns JA; Hofvind S
    Qual Life Res; 2022 Apr; 31(4):1057-1068. PubMed ID: 34698976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general population.
    Teni FS; Gerdtham UG; Leidl R; Henriksson M; Åström M; Sun S; Burström K
    Qual Life Res; 2022 Mar; 31(3):697-712. PubMed ID: 34628587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
    Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life and Chlamydia trachomatis infection in sexually experienced female inner-city students: a community-based cross-sectional study.
    Sri T; Southgate E; Kerry SR; Nightingale C; Oakeshott P
    Int J STD AIDS; 2017 Mar; 28(4):367-371. PubMed ID: 27154958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway.
    Aas CF; Vold JH; Skurtveit S; Lim AG; Ruths S; Islam K; Askildsen JE; Løberg EM; Fadnes LT; Johansson KA;
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):68. PubMed ID: 32883319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving beyond the stage: how characteristics at diagnosis dictate treatment and treatment-related quality of life year losses for women with early stage invasive breast cancer.
    Saxby K; Nickson C; Mann GB; Park A; Bromley H; Velentzis L; Procopio P; Canfell K; Petrie D
    Expert Rev Pharmacoecon Outcomes Res; 2021 Aug; 21(4):847-857. PubMed ID: 33253057
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
    Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
    Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial.
    Xie J; Wang Y; Xu Y; Fine JT; Lam J; Garrison LP
    J Med Econ; 2022; 25(1):51-58. PubMed ID: 34907813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions.
    Shaw JW; Bennett B; Trigg A; DeRosa M; Taylor F; Kiff C; Ntais D; Noon K; King MT; Cocks K
    Value Health; 2021 Nov; 24(11):1651-1659. PubMed ID: 34711366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30.
    van Dongen-Leunis A; Redekop WK; Uyl-de Groot CA
    Value Health; 2016; 19(6):834-843. PubMed ID: 27712712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quebec Health-Related Quality-of-Life Population Norms Using the EQ-5D-5L: Decomposition by Sociodemographic Data and Health Problems.
    Poder TG; Carrier N; Kouakou CRC
    Value Health; 2020 Feb; 23(2):251-259. PubMed ID: 32113631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
    McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
    Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-P.
    Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Hino A; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Noto S; Shimozuma K
    Qual Life Res; 2019 Sep; 28(9):2383-2391. PubMed ID: 31025290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of EQ-5D-5L questionnaire in patients suffering from urinary incontinence.
    Garcia-Gordillo MA; Collado-Mateo D; Olivares PR; Adsuar JC
    Actas Urol Esp; 2016 Sep; 40(7):457-62. PubMed ID: 26975979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norwegian population norms for the EQ-5D-5L: results from a general population survey.
    Garratt AM; Hansen TM; Augestad LA; Rand K; Stavem K
    Qual Life Res; 2022 Feb; 31(2):517-526. PubMed ID: 34272631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
    Lamu AN; Björkman L; Hamre HJ; Alræk T; Musial F; Robberstad B
    Health Qual Life Outcomes; 2021 Apr; 19(1):125. PubMed ID: 33865400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China.
    Huang W; Yang J; Liu Y; Liu C; Zhang X; Fu W; Shi L; Liu G
    BMJ Open; 2018 Dec; 8(12):e022711. PubMed ID: 30530472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating health-related quality of life in gastric cancer patients in Suzhou, China.
    Zhang FF; Ye L; Yin N; Xiong F; Zhao CH; Zhu YB
    Ann Palliat Med; 2021 Jul; 10(7):8024-8033. PubMed ID: 34353087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choice Defines QALYs: A US Valuation of the EQ-5D-5L.
    Craig BM; Rand K
    Med Care; 2018 Jun; 56(6):529-536. PubMed ID: 29668646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
    Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
    Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.